To validate the hypothesis that the protein signature comprising CRYM, PFKL, CAPZA, ALDH16A1, SERPINC1, and HP can distinguish ALS from control subjects, we quantified these six proteins using Western blots in an independent validation cohort (Fig. 3a). This evidence concerns the gene ALDH16A1 and amyotrophic lateral sclerosis.